Altered phenotype of HT29 colonic adenocarcinoma cells following expression of the DCC gene

Anna Velcich, Georgia Corner, Lisa Palumbo, Leonard H. Augenlicht

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

On 18q, frequently deleted in late stage colorectal cancers, a gene, Deleted in Colon Cancer (DCC), has been identified and postulated to play a role as a tumor suppressor gene. DCC is retained in the majority of mucinous tumors, which produce high levels of mucins, and seems to be preferentially expressed in intestinal goblet cells. To investigate whether DCC is related to mucin expression and can modulate the transformed phenotype, we introduced a full-length DCC cDNA into HT29 cells, which can be induced in vitro to express MUC2, the gene that encodes the major colonic mucin. Expression of DCC did not modulate constitutive or induced expression of MUC2, nor did DCC induce a mature goblet cell phenotype. However, HT29 clones expressing high and low levels of DCC protein showed a significant decrease in cell proliferation and tumorigenicity. Furthermore, increased shedding and an elevated rate of spontaneous apoptosis were associated with higher levels of expression of DCC. In summary, while restoration of DCC expression in a human colon carcinoma cell line did not influence expression of differentiation markers, DCC expression did affect the growth and tumorigenic properties of the cells suggesting that DCC can modulate the malignant phenotype of colon cancer.

Original languageEnglish (US)
Pages (from-to)2599-2606
Number of pages8
JournalOncogene
Volume18
Issue number16
DOIs
StatePublished - Apr 22 1999

Fingerprint

Neoplasm Genes
Colonic Neoplasms
Adenocarcinoma
Phenotype
Mucins
Goblet Cells
HT29 Cells
Differentiation Antigens
Tumor Suppressor Genes
Colorectal Neoplasms
Colon
Complementary DNA
Clone Cells
Cell Proliferation
Apoptosis

Keywords

  • Colon cancer
  • DCC
  • MUC2 expression

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Altered phenotype of HT29 colonic adenocarcinoma cells following expression of the DCC gene. / Velcich, Anna; Corner, Georgia; Palumbo, Lisa; Augenlicht, Leonard H.

In: Oncogene, Vol. 18, No. 16, 22.04.1999, p. 2599-2606.

Research output: Contribution to journalArticle

Velcich, Anna ; Corner, Georgia ; Palumbo, Lisa ; Augenlicht, Leonard H. / Altered phenotype of HT29 colonic adenocarcinoma cells following expression of the DCC gene. In: Oncogene. 1999 ; Vol. 18, No. 16. pp. 2599-2606.
@article{88e320c7552845a794ea0def41ce436d,
title = "Altered phenotype of HT29 colonic adenocarcinoma cells following expression of the DCC gene",
abstract = "On 18q, frequently deleted in late stage colorectal cancers, a gene, Deleted in Colon Cancer (DCC), has been identified and postulated to play a role as a tumor suppressor gene. DCC is retained in the majority of mucinous tumors, which produce high levels of mucins, and seems to be preferentially expressed in intestinal goblet cells. To investigate whether DCC is related to mucin expression and can modulate the transformed phenotype, we introduced a full-length DCC cDNA into HT29 cells, which can be induced in vitro to express MUC2, the gene that encodes the major colonic mucin. Expression of DCC did not modulate constitutive or induced expression of MUC2, nor did DCC induce a mature goblet cell phenotype. However, HT29 clones expressing high and low levels of DCC protein showed a significant decrease in cell proliferation and tumorigenicity. Furthermore, increased shedding and an elevated rate of spontaneous apoptosis were associated with higher levels of expression of DCC. In summary, while restoration of DCC expression in a human colon carcinoma cell line did not influence expression of differentiation markers, DCC expression did affect the growth and tumorigenic properties of the cells suggesting that DCC can modulate the malignant phenotype of colon cancer.",
keywords = "Colon cancer, DCC, MUC2 expression",
author = "Anna Velcich and Georgia Corner and Lisa Palumbo and Augenlicht, {Leonard H.}",
year = "1999",
month = "4",
day = "22",
doi = "10.1038/sj.onc.1202610",
language = "English (US)",
volume = "18",
pages = "2599--2606",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "16",

}

TY - JOUR

T1 - Altered phenotype of HT29 colonic adenocarcinoma cells following expression of the DCC gene

AU - Velcich, Anna

AU - Corner, Georgia

AU - Palumbo, Lisa

AU - Augenlicht, Leonard H.

PY - 1999/4/22

Y1 - 1999/4/22

N2 - On 18q, frequently deleted in late stage colorectal cancers, a gene, Deleted in Colon Cancer (DCC), has been identified and postulated to play a role as a tumor suppressor gene. DCC is retained in the majority of mucinous tumors, which produce high levels of mucins, and seems to be preferentially expressed in intestinal goblet cells. To investigate whether DCC is related to mucin expression and can modulate the transformed phenotype, we introduced a full-length DCC cDNA into HT29 cells, which can be induced in vitro to express MUC2, the gene that encodes the major colonic mucin. Expression of DCC did not modulate constitutive or induced expression of MUC2, nor did DCC induce a mature goblet cell phenotype. However, HT29 clones expressing high and low levels of DCC protein showed a significant decrease in cell proliferation and tumorigenicity. Furthermore, increased shedding and an elevated rate of spontaneous apoptosis were associated with higher levels of expression of DCC. In summary, while restoration of DCC expression in a human colon carcinoma cell line did not influence expression of differentiation markers, DCC expression did affect the growth and tumorigenic properties of the cells suggesting that DCC can modulate the malignant phenotype of colon cancer.

AB - On 18q, frequently deleted in late stage colorectal cancers, a gene, Deleted in Colon Cancer (DCC), has been identified and postulated to play a role as a tumor suppressor gene. DCC is retained in the majority of mucinous tumors, which produce high levels of mucins, and seems to be preferentially expressed in intestinal goblet cells. To investigate whether DCC is related to mucin expression and can modulate the transformed phenotype, we introduced a full-length DCC cDNA into HT29 cells, which can be induced in vitro to express MUC2, the gene that encodes the major colonic mucin. Expression of DCC did not modulate constitutive or induced expression of MUC2, nor did DCC induce a mature goblet cell phenotype. However, HT29 clones expressing high and low levels of DCC protein showed a significant decrease in cell proliferation and tumorigenicity. Furthermore, increased shedding and an elevated rate of spontaneous apoptosis were associated with higher levels of expression of DCC. In summary, while restoration of DCC expression in a human colon carcinoma cell line did not influence expression of differentiation markers, DCC expression did affect the growth and tumorigenic properties of the cells suggesting that DCC can modulate the malignant phenotype of colon cancer.

KW - Colon cancer

KW - DCC

KW - MUC2 expression

UR - http://www.scopus.com/inward/record.url?scp=0033594482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033594482&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1202610

DO - 10.1038/sj.onc.1202610

M3 - Article

VL - 18

SP - 2599

EP - 2606

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 16

ER -